PMHNP Study from Vital Boards
Outspoken opponent of NP role - ✔✔Martha Rogers
Treatment for AUD - ✔✔Naltrexone 50mg daily to prevent relapse
Acamprosate - ✔✔resembles GABA and NMDA antagonist. Anti-craving drug used for maintenance
therapy of alcohol withdrawal. Dose 2000 mg/day. Combining acamprosate and naltrexone may be
more beneficial together
Disulfiram- 250mg day - ✔✔What drug is used to prevent alcohol consumption by blocking aldehyde
dehydrogenase?
Naloxone (Narcan) - ✔✔opiate antagonist, reverses opioid induced resiratory depression
Buprenorphine - ✔✔Suboxone- used for detoxification and part of maintenance therapy in opioid
withdrawal.
temporal lobe - ✔✔key role in long-term memory, hearing, and interpretation of visual stimuli
Salvador Minuchin - ✔✔Structural Family Therapy: uses joining, enactment, boundary making, and
mimesis techniques
Carol Anderson and William McFarlane - ✔✔psychoeducational family therapy
Robert Liberman and Lawrence Weathers - ✔✔behavioral family therapy
Michael White & David Epston - ✔✔Narrative Therapy
Inhibitor - ✔✔substance that decreases the metabolism of drugs and leads to higher levels leading to
toxicity
, Inducer - ✔✔a substance that increases the rate of a specific enzyme synthesis from a lower to a
higher level
Cyclothymic Disorder Criteria - ✔✔A) For at least 2 years (at least 1 year in children and adolescents)
there have been numerous periods with hypomanic symptoms that do not meet criteria for a
hypomanic episode and numerous periods with depressive symptoms that do not meet criteria for a
major depressive episode.
B) During the above 2-year period (1 year in children and adolescents), the hypomanic and
depressive periods have been present for at least half the time and the individual has not been
without the symptoms for more than 2 months at a time.
C) Criteria for a major depressive, manic, or hypomanic episode have never been met.
D) The symptoms in Criterion A are not better explained by schizoaffective disorder, schizophrenia,
schizophreniform disorder, delusional disorder, or other specified or unspecified schizophrenia
spectrum and other psychotic disorder.
E) The symptoms are not attributable to the physiological effects of a substance (e.g., a drug of
abuse, a medication) or another medical condition (e.g., hyperthyroidism).
F) The symptoms cause clinically significant distress or impairment in social, occupational, or other
important areas of functioning.
negative reinforcement - ✔✔the reinforcement of a response by the removal, escape from, or
avoidance of an unpleasant stimulus
positive reinforcement - ✔✔Increasing behaviors by presenting positive stimuli, such as food. A
positive reinforcer is any stimulus that, when presented after a response, strengthens the response.
negative punishment - ✔✔the removal of a stimulus to decrease the probability of a behavior's
recurring
positive punishment - ✔✔The application of an undesirable stimulus to reduce specific behavior
Outspoken opponent of NP role - ✔✔Martha Rogers
Treatment for AUD - ✔✔Naltrexone 50mg daily to prevent relapse
Acamprosate - ✔✔resembles GABA and NMDA antagonist. Anti-craving drug used for maintenance
therapy of alcohol withdrawal. Dose 2000 mg/day. Combining acamprosate and naltrexone may be
more beneficial together
Disulfiram- 250mg day - ✔✔What drug is used to prevent alcohol consumption by blocking aldehyde
dehydrogenase?
Naloxone (Narcan) - ✔✔opiate antagonist, reverses opioid induced resiratory depression
Buprenorphine - ✔✔Suboxone- used for detoxification and part of maintenance therapy in opioid
withdrawal.
temporal lobe - ✔✔key role in long-term memory, hearing, and interpretation of visual stimuli
Salvador Minuchin - ✔✔Structural Family Therapy: uses joining, enactment, boundary making, and
mimesis techniques
Carol Anderson and William McFarlane - ✔✔psychoeducational family therapy
Robert Liberman and Lawrence Weathers - ✔✔behavioral family therapy
Michael White & David Epston - ✔✔Narrative Therapy
Inhibitor - ✔✔substance that decreases the metabolism of drugs and leads to higher levels leading to
toxicity
, Inducer - ✔✔a substance that increases the rate of a specific enzyme synthesis from a lower to a
higher level
Cyclothymic Disorder Criteria - ✔✔A) For at least 2 years (at least 1 year in children and adolescents)
there have been numerous periods with hypomanic symptoms that do not meet criteria for a
hypomanic episode and numerous periods with depressive symptoms that do not meet criteria for a
major depressive episode.
B) During the above 2-year period (1 year in children and adolescents), the hypomanic and
depressive periods have been present for at least half the time and the individual has not been
without the symptoms for more than 2 months at a time.
C) Criteria for a major depressive, manic, or hypomanic episode have never been met.
D) The symptoms in Criterion A are not better explained by schizoaffective disorder, schizophrenia,
schizophreniform disorder, delusional disorder, or other specified or unspecified schizophrenia
spectrum and other psychotic disorder.
E) The symptoms are not attributable to the physiological effects of a substance (e.g., a drug of
abuse, a medication) or another medical condition (e.g., hyperthyroidism).
F) The symptoms cause clinically significant distress or impairment in social, occupational, or other
important areas of functioning.
negative reinforcement - ✔✔the reinforcement of a response by the removal, escape from, or
avoidance of an unpleasant stimulus
positive reinforcement - ✔✔Increasing behaviors by presenting positive stimuli, such as food. A
positive reinforcer is any stimulus that, when presented after a response, strengthens the response.
negative punishment - ✔✔the removal of a stimulus to decrease the probability of a behavior's
recurring
positive punishment - ✔✔The application of an undesirable stimulus to reduce specific behavior
